Twist Bioscience Corp — Director's Dealing 2020

Feb 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-02-18

Reporting Person: Weiss Patrick (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-18	Common Stock	S	3492	$30.689	Disposed	76377	Direct
2020-02-18	Common Stock	S	598	$30.722	Disposed	75779	Direct
2020-02-19	Common Stock	S	1742	$28.659	Disposed	74037	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $30.36 to $31.02 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $30.44 to $31.23 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.22 to $29.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.